Come up with a name for your new list and we'll add to it:
Akari Therapeutics raised a round of funding on , . Investors include
New Enterprise Associates.
Akari, formerly Celsus Therapeutics, is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases…